Zacks Investment ResearchTue, 02 Jun 2026 17:01:07 GMTWhat Makes BioXcel Therapeutics (BTAI) a New Buy StockBTAI+3.97%
Zacks Investment ResearchFri, 15 May 2026 13:16:07 GMTBioXcel Therapeutics, Inc. (BTAI) Reports Q1 Loss, Lags Revenue EstimatesBTAI+3.97%
Zacks Investment ResearchMon, 04 May 2026 15:06:22 GMTBioXcel Therapeutics, Inc. (BTAI) Expected to Beat Earnings Estimates: Should You Buy?BTAI+3.97%
Seeking AlphaFri, 24 Apr 2026 14:31:34 GMTBioXcel Therapeutics, Inc. (BTAI) Discusses Commercial Launch Strategy and Market Opportunity for IGALMI in At-Home Setting TranscriptBTAI+3.97%